{"originalText": "，缘于入院前1月余诊断“直乙交界处结肠癌”，于2013.11.11在我科行“腹腔镜上直乙交界处结肠癌根治术”，术中见腹腔内无明显腹水，未见明显转移结节，乙状结肠稍迂曲，肿瘤位于直肠-乙状结肠交界处，上缘距腹膜返折约7CM，约5×4CM，侵及浆膜层，未侵犯周围组织，未形成明显梗阻，周围未见明显肿大淋巴结。术顺，术毕安返病房，予补液及营养对症支持等治疗。术后病理（20335111），示：（直肠）大肠隆起型管状腺癌II级，侵犯外膜层，手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肿物周围淋巴结11个，肠周淋巴结21个，及另送（肠系膜上动脉根部）淋巴结5个，均未见癌转移。，免疫组化结果：CK20(+)，CK7(-)，VILLIN(+++)，CEA(++)，CDX-2(++)，CD56(-)，CGA（个别+），SY(个别+)，KI67(85%+)。术后恢复出院，后于2013.12.05开始予“奥沙利铂150MGIVGTTD1+希罗达1000MGPOBIDD2-15”方案行术后第1周期化疗，辅以保胃、保肝、止吐等治疗，过程顺利。现为求术后第2周期化疗再次就诊我院，门诊拟“直乙交界处结肠癌术后”收入院。自下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 20}, {"end_pos": 53, "label_type": "手术", "overlap": 0, "start_pos": 38}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 193, "end_pos": 209}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 410, "label_type": "药物", "overlap": 0, "start_pos": 406}, {"end_pos": 426, "label_type": "药物", "overlap": 0, "start_pos": 423}, {"end_pos": 459, "label_type": "解剖部位", "overlap": 0, "start_pos": 458}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 461}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 496, "end_pos": 506}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 529}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 532}]}
